Lesion evolution and neurodegeneration in RVCL-S

Objective To characterize lesion evolution and neurodegeneration in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) using multimodal MRI. Methods We prospectively performed MRI and cognitive testing in RVCL-S and healthy control cohorts. Gray and white matter volume and disruption of white matter microstructure were quantified. Asymmetric spin echo acquisition permitted voxel-wise oxygen extraction fraction (OEF) calculation as an in vivo marker of microvascular ischemia. The RVCL-S cohort was included in a longitudinal analysis of lesion subtypes in which hyperintense lesions on fluid-attenuated inversion recovery (FLAIR), T1-postgadolinium, and diffusion-weighted imaging were delineated and quantified volumetrically. Results Twenty individuals with RVCL-S and 26 controls were enrolled. White matter volume and microstructure declined faster in those with RVCL–S compared to controls. White matter atrophy in RVCL-S was highly linear (ρ = −0.908, p < 0.0001). Normalized OEF was elevated in RVCL-S and increased with disease duration. Multiple cognitive domains, specifically those measuring working memory and processing speed, were impaired in RVCL-S. Lesion volumes, regardless of subtype, progressed/regressed with high variability as a function of age, while FLAIR lesion burden increased near time to death (p < 0.001). Conclusion RVCL-S is a monogenic microvasculopathy affecting predominantly the white matter with regard to atrophy and cognitive impairment. White matter volumes in RVCL-S declined linearly, providing a potential metric against which to test the efficacy of future therapies. Progressive elevation of white matter OEF suggests that microvascular ischemia may underlie neurodegeneration in RVCL-S.

[1]  R. Pagon,et al.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations , 2020, Definitions.

[2]  T. Huber,et al.  Magnetic Resonance Imaging Characteristics of Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations , 2019, Clinical Neuroradiology.

[3]  M. Ferrari,et al.  Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease , 2018, Journal of internal medicine.

[4]  R. Schmidt,et al.  TREX1 is expressed by microglia in normal human brain and increases in regions affected by ischemia , 2018, Brain pathology.

[5]  Q. Almeida,et al.  State Anxiety Predicts Cognitive Performance in Patients With Parkinson’s Disease , 2018, Neuropsychology.

[6]  J. Boockvar,et al.  Retinal vasculopathy with cerebral leukoencephalopathy (RVCL) , 2018, Neurology.

[7]  David L. Lahna,et al.  Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time , 2018, Neurology.

[8]  D. Norris,et al.  Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity , 2018, Stroke.

[9]  C. Tzourio,et al.  Anxiety and 10-Year Risk of Incident Dementia—An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study , 2018, Front. Neurosci..

[10]  Yasheng Chen,et al.  Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease , 2018, Neurology.

[11]  Yasheng Chen,et al.  Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia. , 2018, Blood.

[12]  O. Godefroy,et al.  Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant? , 2018, Journal of Alzheimer's disease : JAD.

[13]  Juliana Rumy Tsuchihashi Takeda,et al.  Cardiovascular risk factors and cognitive performance in aging , 2017, Dementia & neuropsychologia.

[14]  O. Khalaf,et al.  Late versus Early Onset Depression in Elderly Patients: Vascular Risk and Cognitive Impairment. , 2017, Current aging science.

[15]  Nan Yan,et al.  DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice. , 2017, Journal of autoimmunity.

[16]  Tzu-Lan Wang,et al.  Frontal Assessment Battery as a Useful Tool to Differentiate Mild Cognitive Impairment due to Subcortical Ischemic Vascular Disease from Alzheimer Disease , 2016, Dementia and Geriatric Cognitive Disorders.

[17]  P. Kempster,et al.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. , 2016, Brain : a journal of neurology.

[18]  S. Studenski,et al.  Digit Symbol Substitution test and future clinical and subclinical disorders of cognition, mobility and mood in older adults. , 2016, Age and ageing.

[19]  J. Xu,et al.  The Montreal cognitive assessment is superior to national institute of neurological disease and stroke-Canadian stroke network 5-minute protocol in predicting vascular cognitive impairment at 1 year , 2016, BMC Neurology.

[20]  Derek H. Oakley,et al.  A 44‐year‐old man with eye, kidney, and brain dysfunction , 2016, Annals of neurology.

[21]  Z. Liu,et al.  Cortical Cerebral Blood Flow, Oxygen Extraction Fraction, and Metabolic Rate in Patients with Middle Cerebral Artery Stenosis or Acute Stroke , 2016, American Journal of Neuroradiology.

[22]  Fenella J Kirkham,et al.  A general model to calculate the spin-lattice (T1) relaxation time of blood, accounting for haematocrit, oxygen saturation and magnetic field strength , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  D. Schiff,et al.  Evolution of brain lesions in a patient with TREX1 cerebroretinal vasculopathy , 2015, Neurology.

[24]  Nan Yan,et al.  Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation. , 2015, Immunity.

[25]  E. Vittinghoff,et al.  Intima-Media Thickness and Cognitive Function in Stroke-Free Middle-Aged Adults: Findings From the Coronary Artery Risk Development in Young Adults Study , 2015, Stroke.

[26]  R. Marshall,et al.  Indirect measures of arterial stiffness and cognitive performance in individuals without traditional vascular risk factors or disease. , 2015, JAMA neurology.

[27]  Rohit Bakshi,et al.  Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[28]  R. Schmidt,et al.  Neuropathology and Genetics of Cerebroretinal Vasculopathies , 2014, Brain pathology.

[29]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[30]  Victoria J. Williams,et al.  Association between white matter microstructure, executive functions, and processing speed in older adults: The impact of vascular health , 2013, Human brain mapping.

[31]  B. Avants,et al.  Longitudinal reproducibility and accuracy of pseudo-continuous arterial spin-labeled perfusion MR imaging in typically developing children. , 2012, Radiology.

[32]  M. O’Sullivan,et al.  Verbal memory impairment in subcortical ischemic vascular disease A descriptive analysis in CADASIL , 2011, Neurobiology of Aging.

[33]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[34]  J. Atkinson,et al.  EVOLUTION OF A TUMOR-LIKE LESION IN CEREBRORETINAL VASCULOPATHY AND TREX1 MUTATION , 2010, Neurology.

[35]  M. Dichgans,et al.  Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy , 2010, Journal of Neurology.

[36]  D. Barnes,et al.  Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease. , 2009, Biochemical Society transactions.

[37]  S. Fritz,et al.  White paper: "walking speed: the sixth vital sign". , 2009, Journal of geriatric physical therapy.

[38]  Roland Bammer,et al.  Cognitive processing speed and the structure of white matter pathways: Convergent evidence from normal variation and lesion studies , 2008, NeuroImage.

[39]  J. Detre,et al.  A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling , 2007, Magnetic resonance in medicine.

[40]  S. Nelson,et al.  C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.

[41]  J. DeLuca,et al.  Is Speed of Processing or Working Memory the Primary Information Processing Deficit in Multiple Sclerosis? , 2004, Journal of clinical and experimental neuropsychology.

[42]  Timothy Edward John Behrens,et al.  Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.

[43]  Weili Lin,et al.  Impact of intravascular signal on quantitative measures of cerebral oxygen extraction and blood volume under normo‐ and hypercapnic conditions using an asymmetric spin echo approach , 2003, Magnetic resonance in medicine.

[44]  Weili Lin,et al.  Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients , 2003, Annals of neurology.

[45]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[46]  William J Powers,et al.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. , 2002, Brain : a journal of neurology.

[47]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[48]  H. Buschke,et al.  Implicit and explicit memory in young, old, and demented adults. , 1992, Journal of clinical and experimental neuropsychology.

[49]  J. Atkinson,et al.  Cerebroretinal vasculopathy. A new hereditary syndrome. , 1988, Ophthalmology.

[50]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[51]  C. Spielberger,et al.  Validation of the State-Trait Distinction in Anxiety Research. , 1975, Multivariate Behavioral Research.